MULTIMERICS ApS
CVRCVR number31603390
Company financials
Key figures
Updated 13 Jul 2026
- Return on assets
- -19.2%
- Return on equity
- -51%
- Current ratio
- 160.3%
- Equity ratio
- 37.6%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | -3,300 |
Operating profit | -3,300 |
Finance income | 1 |
Profit/loss for the year | -3,299 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 1 |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 4,015 |
Current assets | 17,196 |
Total assets | 17,196 |
Equity | 6,470 |
Liabilities | 10,726 |
Current liabilities | 10,726 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 125,000 |
Retained earnings | -118,530 |
Annual report highlights
Official annual report · 2025
Business and development
Primary activities
Selskabets væsentligste aktiviteter har i lighed med tidligere år bestået af at udvikle og kommercialisere funktionelle protein produkter til profylaktisk og terapeutisk brug ved passiv immunisering af dyr og mennesker samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Udviklingen i selskabets aktiviteter og økonomiske forhold…
Create a free account to see up to 9 years of financial history
Create free account